Literature DB >> 33121985

A pan-cancer analysis of molecular characteristics and oncogenic role of hexokinase family genes in human tumors.

Mingzhe Jiang1, Shuangjie Liu2, Jiaxing Lin1, Wenjun Hao3, Baojun Wei1, Ying Gao1, Chuize Kong1, Meng Yu4, Yuyan Zhu5.   

Abstract

Hexokinase (HK) plays a key role in various biological processes such as glycolysis of tumor cells. However, there is still a lack of systematic understanding of the contribution of HK family genes in different types of cancer. In the present study, we systematically analyzed the molecular changes and clinical correlations of HK family genes in 33 types of cancer extracted from more than 10,000 subjects. As a result, there were extensive genetic changes in HK family genes and the expression levels of HK family were significantly correlated with the activity of cancer marker-related pathways. In addition, HK family genes may be useful in predicting prognosis and therapeutic efficacy. Moreover, HK1,HK2 and HK3 may become potential oncogenes across a variety of cancer types. Furthermore, the oncogenic functions of HK1 in bladder cancer have been confirmed in vitro. Collectively, our results provide valuable resources to guide the mechanism and therapeutic analysis concerning the role of HK family genes in cancer.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Biomarker; Hexokinase; Pan-cancer analysis; TCGA; Therapeutic target

Mesh:

Substances:

Year:  2020        PMID: 33121985     DOI: 10.1016/j.lfs.2020.118669

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Lipocalin-2 inhibits pancreatic cancer stemness via the AKT/c-Jun pathway.

Authors:  Peipei Hao; Jiamin Zhang; Shu Fang; Miaomiao Jia; Xian Xian; Sinan Yan; Yunpeng Wang; Qian Ren; Fengming Yue; Huixian Cui
Journal:  Hum Cell       Date:  2022-07-06       Impact factor: 4.374

Review 2.  miR-30d-5p: A Non-Coding RNA With Potential Diagnostic, Prognostic and Therapeutic Applications.

Authors:  Qinlu Zhao; Xin Yuan; Lian Zheng; Miaomiao Xue
Journal:  Front Cell Dev Biol       Date:  2022-01-27

3.  Identification and validation of an epigenetically regulated long noncoding RNA model for breast cancer metabolism and prognosis.

Authors:  Yu Song; Songjie Shen; Qiang Sun
Journal:  BMC Med Genomics       Date:  2022-05-07       Impact factor: 3.622

4.  FBP1 /miR-24-1/enhancer axis activation blocks renal cell carcinoma progression via Warburg effect.

Authors:  Dongen Ju; Ying Liang; Guangdong Hou; Wanxiang Zheng; Geng Zhang; Xinlong Dun; Di Wei; Fei Yan; Lei Zhang; Dong Lai; Jiarui Yuan; Yu Zheng; Fuli Wang; Ping Meng; Yong Wang; Wenqiang Yu; Jianlin Yuan
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

5.  3-Bromopyruvic acid regulates glucose metabolism by targeting the c-Myc/TXNIP axis and induces mitochondria-mediated apoptosis in TNBC cells.

Authors:  Jiachen Li; Jianmin Pan; Yang Liu; Xiaohui Luo; Cheng Yang; Wangfa Xiao; Qishang Li; Lihui Yang; Xiaodong Zhang
Journal:  Exp Ther Med       Date:  2022-06-16       Impact factor: 2.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.